Isotretinoin increases skin-surface levels of neutrophil gelatinase-associated lipocalin in patients treated for severe acne

Summary Background  A clear‐cut need exists for safe and effective alternatives to the use of isotretinoin in severe acne. Lack of data regarding the specifics of isotretinoin’s mechanism of action has hampered progress in this area. Recently, the protein neutrophil gelatinase‐associated lipocalin (...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of dermatology (1951) Vol. 165; no. 2; pp. 302 - 310
Main Authors Lumsden, K.R., Nelson, A.M., Dispenza, M.C., Gilliland, K.L., Cong, Z., Zaenglein, A.L., Thiboutot, D.M.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2011
Wiley-Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary Background  A clear‐cut need exists for safe and effective alternatives to the use of isotretinoin in severe acne. Lack of data regarding the specifics of isotretinoin’s mechanism of action has hampered progress in this area. Recently, the protein neutrophil gelatinase‐associated lipocalin (NGAL) has been identified as a mediator of the apoptotic effect of isotretinoin on sebocytes. Objectives  To establish further the clinical relevance of NGAL and to elucidate the factors that induce NGAL expression in sebocytes. Methods  Methods were developed to isolate and quantify skin‐surface levels of NGAL from normal subjects and patients with acne undergoing treatment with isotretinoin. Results  Patients with acne were found to have higher skin levels of NGAL compared with normal subjects. Studies in SEB‐1 sebocytes indicate that NGAL expression is increased in response to Propionibacterium acnes and interleukin (IL)‐1β. In patients, isotretinoin increases NGAL levels by 2·4‐fold on the skin surface and this increase precedes decreases in sebum and P. acnes counts. Conclusions  These data support the hypothesis that NGAL is an important mediator of the early effects of isotretinoin on the sebaceous glands and provide insights into the mechanisms that regulate NGAL expression in the skin.
Bibliography:ark:/67375/WNG-LPN39NVZ-5
ArticleID:BJD10362
istex:ACDDA9221C109BEA29C2B4779A39C391CA51A276
Funding sources
This work was supported by NIH NIAMS grants F31AR054723‐01 to K.R.L., RO1AR047820 to D.M.T., NIH General Clinical Research Center grants M01RR010732 and C06RR016499 to The Pennsylvania State University College of Medicine and the Jake Gittlen Cancer Research Foundation at the Pennsylvania State University College of Medicine.
Conflicts of interest
None declared.
Present address of A.M. Nelson: Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, MD 21231, U.S.A.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
current address: Johns Hopkins School of Medicine, Department of Dermatology, Baltimore, MD 21231.
ISSN:0007-0963
1365-2133
1365-2133
DOI:10.1111/j.1365-2133.2011.10362.x